论文部分内容阅读
目的探究厄贝沙坦片联合银杏达莫注射液治疗糖尿病肾病的临床疗效。方法选取2014年11月—2015年12月在该院接受治疗的122例糖尿病肾病患者为研究对象,依据治疗方式差异分为实验组和对照组,对照组患者接受厄贝沙坦药物治疗,实验组患者接受银杏达莫注射液联合厄贝沙坦药物治疗,分析两组患者的症候积分、临床疗效及各项临床指标。结果经过治疗后,实验组患者的治疗总有效率明显高于对照组患者;且实验组患者的TC、TG、Bun、Ser、UAER等指标、以及五心烦热、消谷善饥、口干口渴、乏力等症候积分均明显优于对照组患者。结论厄贝沙坦片联合银杏达莫注射液可以显著改善患者的症候积分和临床症状,并能有效提高临床疗效,值得在糖尿病肾病治疗过程中继续推广使用。
Objective To investigate the clinical efficacy of irbesartan tablets combined with Yinxingdamo injection in the treatment of diabetic nephropathy. Methods A total of 122 patients with diabetic nephropathy who were treated in the hospital from November 2014 to December 2015 were selected as the experimental group and the control group according to the differences in treatment methods. The patients in the control group received irbesartan drug treatment. The experiment The patients in group received Ginkgo-damo injection combined with irbesartan drug treatment, and the symptom scores, clinical efficacy and various clinical indexes of the two groups were analyzed. Results After treatment, the total effective rate of the experimental group was significantly higher than that of the control group. The TC, TG, Bun, Ser, UAER and other indicators of the experimental group as well as five heartburn, Thirst, fatigue and other symptoms were significantly better than the control group patients. Conclusion Irbesartan tablets combined with Yinxingdamo injection can significantly improve the patient’s symptom scores and clinical symptoms, and can effectively improve the clinical efficacy, it is worth in the treatment of diabetic nephropathy continue to promote the use of.